Surveillance Without Chemotherapy in a Woman with Recurrent Molar Pregnancy

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2013 Feb 23

PMID 23429019

Authors

Rashmi Bagga

Sujata Siwatch

Radhika Srinivasan

Lakhbir Kaur Dhaliwal

Affiliations

Soon will be listed here.

Abstract

A 27-year-old fouth gravida patient with previous two partial molar pregnancies and one missed abortion underwent a suction evacuation for partial molar pregnancy at 9 weeks of gestation. She was followed up with serum HCG values. Though the HCG level reduced from a pre-evacuation value of 1 40 223-31 157 mIU/ml 1 week post procedure, the levels continued to be positive in low titres 6 months after suction evacuation. The management options were discussed with the patient and a decision was taken to continue surveillance with serial HCG titres. HCG levels normalised after 11 months without the need for chemotherapy.

References

Hancock B, Nazir K, Everard J . Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med. 2006; 51(10):764-6. View

Boafo-Yirenki M, Everard J, Tidy J, Hancock B . A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia. J Reprod Med. 2009; 54(5):288-90. View

Cole L, Muller C . Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. Gynecol Oncol. 2009; 116(1):3-9. DOI: 10.1016/j.ygyno.2009.09.028. View

Powles T, Young A, Sanitt A, Sammit A, Stebbing J, Short D . The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours. Br J Cancer. 2006; 95(9):1145-7. PMC: 2360575. DOI: 10.1038/sj.bjc.6603416. View

Agarwal R, Teoh S, Short D, Harvey R, Savage P, Seckl M . Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study. Lancet. 2011; 379(9811):130-5. PMC: 3262143. DOI: 10.1016/S0140-6736(11)61265-8. View

Bagshawe K, Dent J, Webb J . Hydatidiform mole in England and Wales 1973-83. Lancet. 1986; 2(8508):673-7. DOI: 10.1016/s0140-6736(86)90179-0. View

Koc S, Ozdegirmenci O, Tulunay G, Ozgul N, Kose M, Bulbul D . Recurrent partial hydatidiform mole: a report of a patient with three consecutive molar pregnancies. Int J Gynecol Cancer. 2006; 16(2):940-3. DOI: 10.1111/j.1525-1438.2006.00232.x. View

Seckl M, Fisher R, Salerno G, Rees H, Paradinas F, Foskett M . Choriocarcinoma and partial hydatidiform moles. Lancet. 2000; 356(9223):36-9. DOI: 10.1016/S0140-6736(00)02432-6. View

Schmid P, Nagai Y, Agarwal R, Hancock B, Savage P, Sebire N . Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet. 2009; 374(9683):48-55. DOI: 10.1016/S0140-6736(09)60618-8. View

10.

Sebire N, Fisher R, Foskett M, Rees H, Seckl M, Newlands E . Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2002; 110(1):22-6. View

11.

Palmieri C, Fisher R, Sebire N, Lindsay I, Smith J, McCluggage W . Placental site trophoblastic tumour arising from a partial hydatidiform mole. Lancet. 2005; 366(9486):688. DOI: 10.1016/S0140-6736(05)67143-7. View

12.

Palmieri C, Dhillon T, Ann Fisher R, Young A, Short D, Mitchell H . Management and outcome of healthy women with a persistently elevated beta-hCG. Gynecol Oncol. 2007; 106(1):35-43. DOI: 10.1016/j.ygyno.2007.01.053. View